Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-02
2010-12-14
Landau, Sharmila Gollamudi (Department: 1611)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S359000, C548S250000
Reexamination Certificate
active
07851494
ABSTRACT:
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
REFERENCES:
patent: 4011321 (1977-03-01), Coates
patent: 4098816 (1978-07-01), Thorne et al.
patent: 4474809 (1984-10-01), Floyd, Jr. et al.
patent: 4638094 (1987-01-01), Nakai et al.
patent: 4845231 (1989-07-01), Kees
patent: 5591862 (1997-01-01), Sohda et al.
patent: 5665387 (1997-09-01), Mathieu et al.
patent: 5817693 (1998-10-01), Cousins et al.
patent: 5948803 (1999-09-01), Maeda et al.
patent: 6045773 (2000-04-01), Isakson et al.
patent: 6376512 (2002-04-01), Jayyosi et al.
patent: 6403636 (2002-06-01), Reutrakul et al.
patent: 6555536 (2003-04-01), Burris et al.
patent: 6858602 (2005-02-01), Sharma et al.
patent: 6916848 (2005-07-01), Sharma
patent: 6924314 (2005-08-01), Sharma et al.
patent: 6946491 (2005-09-01), Sharma et al.
patent: 7012071 (2006-03-01), Sharma et al.
patent: 7041659 (2006-05-01), Sharma
patent: 7045541 (2006-05-01), Sharma
patent: 7101910 (2006-09-01), Sharma
patent: 2002/0028943 (2002-03-01), Griffin
patent: 2003/0191323 (2003-10-01), Ikawa et al.
patent: 2004/0214901 (2004-10-01), Antel et al.
patent: 2005/0090555 (2005-04-01), Sharma et al.
patent: 2005/0256333 (2005-11-01), Sharma et al.
patent: 2006/0014784 (2006-01-01), Hodge et al.
patent: 2006/0035970 (2006-02-01), Hodge et al.
patent: 2007/0105955 (2007-05-01), Hodge et al.
patent: 2007/0105958 (2007-05-01), Sharma et al.
patent: 2007/0173544 (2007-07-01), Hodge et al.
patent: 2007/0249696 (2007-10-01), Sharma et al.
patent: 2007/0249719 (2007-10-01), Sharma et al.
Worman, JW. Alcoholic liver disease. http://www.cumc.columbia.edu/ dept/ gi/alcohol.html. electronic pp. 1-3.
Clark, JM. Weight loss as a treatment for nonalcoholic fatty liver disease. Management. Journal of Clinical Gastroenterology. Nonalcoholic steatohepatitis. 40 Suppl. 1: S39-S43, Mar. 2006, abstract only.
Bugianesi et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. American Journal of Gastroenterology. 2005;100:1082-1090.
Bright et al. Competitive particle concentration fluorescence immunoassays for measuring anti-diabetic drug levels in mouse plasma. Journal of Immunological Methods. 1997;207:23-31.
Herfinal. Clinical Pharmacy & Therapeutics (5th ed.). 1992;307-331.
Mahler, R. J., et al. (1999) J. Clin. Endocrinol. Metab. 84(4); p. 1165-1171.
Worman, JW. Alcoholic liver disease, http://www.cumc.columbia.edu/dept/gi/alcohol.html, electronic pp. 1-3; (1995); accessed online Dec. 4, 2007.
Compound having Chemical Abstract RN 60525-32-8, entered STN: Nov. 16, 1984.
Pending (as of Aug. 20, 2007) claims from U.S. Appl. No. 11/481,508.
Pending (as of Sep. 20, 2007) claims from U.S. Appl. No. 10/566,302.
Pending (as of Sep. 19, 2007) claims from U.S. Appl. No. 11/909,120.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No. 11/772,515.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No. 11/772,520.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No. 11/772,556.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No. 11/772,560.
Pending (as of Aug. 24, 2007) claims from U.S. Appl. No. 11/844,431.
Pending (as of Aug. 24, 2007) claims from U.S. Appl. No. 11/844,432.
Pending (as of Aug. 20, 2007) claims from U.S. Appl. No. 11/841,489.
Abstract of Hungarian application No. P0201810, dated Jun. 27, 2000, corresponding to U.S. Patent No. 6,403,636.
Abstract of Hungarian application No. P0101022, dated Oct. 10, 1998, corresponding to U.S. Patent No. 6,376,512.
Abstract of Hungarian application No. P8302786, dated Aug. 5, 1983, corresponding to U.S. Patent No. 4,638,094.
Chemical Abstract Document No. 135:371896, Accession No. 2001:624811, corresponding to Karche, et al., “Electronic Effects in Migratory Groups . . . ” Journal of Organic Chemistry, vol. 66, No. 19, pp. 6323-6332, 2001.
Chemical Abstract Document No. 134:281116; Accession No. 2001:118546, corresponding to Poupardin, et al., “First approach to the cycloisodityrosine unit of RA-IV”, Tetrahedron Letters, vol. 42, No. 8, pp. 1523-1526, 2001.
Chemical Abstract Document No. 130:338298, Accession No. 1999:278112, corresponding to Manthey, et al., “Synthesis of Human Ultraviolet Filter Compounds . . . ” Journal of Organic Chemistry, vol. 64, No., 11, pp. 3930-3933, 1999.
Chemical Abstract Document No. 130:139144, Accession No. 1999: 124556 corresponding to Wu, et al., “Improvement on the preparation of beta-keto esters”, Huaxue Shiji, vol. 20, No. 6, pp. 376-377, 1998.
Chemical Abstract Document No. 128: 167303, Accession No. 1998: 88603, corresponding to Wu, et al., “Total syntheses of furoguaiacin and related analogs”, Huaxue Yanjiu Yu Yingyoung, vol. 9, No. 6, pp. 595-599, 1997.
Chemical Abstract Document No. 128:154358, Accession No. 1998:45825, corresponding to Fadnavis, et al., “Baker's yeast mediated enantiospecific of anti-(2R,3R) . . . ”, Tetrahedron Asymmetry, vol. 8, No. 24, pp. 4003-4006, 1997.
Chemical Abstract Document No. 126:224841, Accession No. 1997:125112, corresponding to Wu, et al., “A modification of the Knorr oxidative coupling method for preparation of 1,4-diketones”, Synthetic Communications, vol. 27, No. 2, pp. 331-336, 1997.
Chemical Abstract Document No. 126:31598, Accession No. 1996:668635, corresponding to Girard, et al., “Syntheses of the syn and anti .alpha .-amino-.beta.-hydroxy acid of vancomycin . . . ” Tetrahedron Letters, vol. 37, No. 44, pp. 7967-7970. 1996.
Chemical Abstract Document No. 125:195315, Accession No. 1996:380971, corresponding to Smith, et al.“Synthesis and PAF antagonist activity of some 2,5-diaryltetrahydrofurans incorporation PAF-like functional groups”, European Journal of Medicinal Chemistry, vol. 31, No. 5, pp. 347-358, 1996.
Chemical Abstract Document No. 121:82852, Accession No. 1994:482852 corresponding to Maruyama, et al., “A synthesis of (.+−.)-pinoresinol and its related compound using potassium persulfate (K2S208) oxidation of benzoylacetates”, Heterocycles, vol. 37, No. 2, pp. 839-845, 1994.
Chemical Abstract Document No. 120:245746, Accession No. 1994:245746 corresponding to Rao, et al., “Studies on cyclodepsipeptides. Part II. The total synthesis of jaspamide and geodiamolide-D”, Tetrahedron Letters, vol. 34, No. 44, pp. 7085-7088, 1993.
Chemical Abstract Document No. 116:227652, Accession No. 1992:227652 corresponding to Colotta, et al., “Tricyclic heteroaromatic systems . . . ”, Farmaco, vol. 46, No. 10, pp. 1139-1154, 1991.
Chemical Abstract Document No. 115:126627, Accession No. 1991:526627 corresponding to Dillard, et al., “(Phenylmethoxy) phenyl derivatives of w-oxo and w-tetrazolylalkanoic acids . . . ” J. Med. Chem., vol. 34, No. 9, pp. 2768-2778, 1991.
Chemical Abstract Document No. 115:91892, Accession No. 1991:491892 corresponding to Bose, et al., “Synthesis of 4-phenylcoumarins fromDalbergia volubilisandExostema caribaeum”, Phytochemistry, vol. 30, No. 7, pp. 2438-2439. 1991.
Chemical Abstract Document No. 113:191095, Accession No. 1990:591095, corresponding to Bose, et al., “Synthesis of 4-phenylcoumarins”, Indian J. Chem., Sect. B, vol. 29B, No. 5, pp. 422-444, 1990.
Chemical Abstract Document No. 113:108732, Accession No. 1990:508732 corresponding to Colotta, et al., “Tricyclic heteroaromatic systems . . . ”, J. Med. Chem., vol. 33, No. 9, pp. 2646-2651, 1990.
Chemical Abstract Document No. 111:108486, Accession No. 1989:508486 corresponding to Kameo, et al., “Studies on hypolipidemic agents, IV. 3-[4-(Phenylthio) benzoyl] propionic acid derivatives”, Chem. Pharm. Bull., vol. 37, No. 5, pp. 1260-1267, 1989.
Chemical Abstract Document No. 111:70311, Accession No. 1989:470311 corresponding to Colotta, et al., “Tricyclic heteroaromatic systems: sy
Bamat Michael K.
Hodge Kirvin L.
Sharma Shalini
von Borstel Reid W.
Wolpe Stephen D.
Kreisler Lewis J.
Landau Sharmila Gollamudi
Orwig Kevin S
Wellstat Therapeutics Corporation
LandOfFree
Method for the treatment of metabolic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of metabolic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of metabolic disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4181754